Education
About Us
Working with TipRanks
Follow Us
Rockwell Medical Technologies (RMTI)
NASDAQ:RMTI
RMTI Stock Chart & Stats
$0.96
-$0.08(-3.59%)
At close: 4:00 PM EST
$0.96
-$0.08(-3.59%)
Day’s Range― - ―
52-Week Range$0.78 - $2.41
Previous CloseN/A
Volume98.98K
Average Volume (3M)520.77K
Market Cap
$36.84M
Enterprise ValueN/A
Total Cash (Recent Filing)$23.71M
Total Debt (Recent Filing)$13.13M
Price to Earnings (P/E)―
Beta1.78
Next Earnings
Mar 26, 2026EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding34,430,350
10 Day Avg. Volume418,188
30 Day Avg. Volume520,771
Financial Highlights & Ratios
PEG Ratio1.42
Price to Book (P/B)1.94
Price to Sales (P/S)0.62
P/FCF Ratio19.86
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$3.75Price Target Upside290.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Contractual StabilityAs of the end of 3Q25, more than 80% of Rockwell Medical's customers remain under long-term contracts.
Market PositionThe company is the largest supplier of liquid bicarbonate concentrates and the second-largest supplier of acid and dry bicarbonate concentrates for dialysis patients in the U.S.
Strategic GrowthRockwell Medical is building momentum on the West Coast and in the at-home dialysis market, which are seen as two key growth opportunities.
Bears Say
Contract Revenue ImpactGiven the current outlook, we have adjusted our long-term forecasts amid the recognition that the company's revenue base—while meaningfully more diversified currently than in the past—may not benefit from large contracts as much as in the past.
Customer Order TrendsWe expect a gradual decline in ordering from its longtime largest customer, although this should be offset by new contracts.
Revenue PerformanceThe company recorded total revenue of $15.9M, modestly below our forecast of $16.8M.
Rockwell Med News
RMTI FAQ
What was Rockwell Medical Technologies’s price range in the past 12 months?
Rockwell Medical Technologies lowest stock price was $0.78 and its highest was $2.41 in the past 12 months.
What is Rockwell Medical Technologies’s market cap?
Rockwell Medical Technologies’s market cap is $36.84M.
When is Rockwell Medical Technologies’s upcoming earnings report date?
Rockwell Medical Technologies’s upcoming earnings report date is Mar 26, 2026 which is in 117 days.
How were Rockwell Medical Technologies’s earnings last quarter?
Rockwell Medical Technologies released its earnings results on Nov 12, 2025. The company reported -$0.05 earnings per share for the quarter, missing the consensus estimate of -$0.045 by -$0.005.
Is Rockwell Medical Technologies overvalued?
According to Wall Street analysts Rockwell Medical Technologies’s price is currently Undervalued.
Does Rockwell Medical Technologies pay dividends?
Rockwell Medical Technologies does not currently pay dividends.
What is Rockwell Medical Technologies’s EPS estimate?
Rockwell Medical Technologies’s EPS estimate is -0.04.
How many shares outstanding does Rockwell Medical Technologies have?
Rockwell Medical Technologies has 34,430,350 shares outstanding.
What happened to Rockwell Medical Technologies’s price movement after its last earnings report?
Rockwell Medical Technologies reported an EPS of -$0.05 in its last earnings report, missing expectations of -$0.045. Following the earnings report the stock price went down -8.571%.
Which hedge fund is a major shareholder of Rockwell Medical Technologies?
Currently, no hedge funds are holding shares in RMTI
Rockwell Med Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.75 (290.63% Upside)
$3.75 (290.63% Upside)
Insider Transactions
Sold Shares
Worth $4.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-77.41%
12-Months-Change
Fundamentals
Return on Equity
-16.67%
Trailing 12-Months
Asset Growth
-0.76%
Trailing 12-Months
Company Description
Rockwell Medical Technologies
Rockwell Medical, Inc. (RMTI) is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD). The company specializes in providing dialysis products and therapies, particularly its proprietary product, Triferic, which is designed to treat iron deficiency in patients undergoing hemodialysis. RMTI operates primarily in the healthcare sector, targeting renal care and improving patient outcomes through its unique treatment solutions.
RMTI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a period of transition and mixed results for Rockwell Medical. Despite achieving profitability on an adjusted EBITDA basis and successfully strengthening its contract portfolio, the company faced significant challenges with declining net sales, gross profit, and ongoing customer transition issues. The improved cash position and expansion of the customer base are positive signs, but significant hurdles remain.View all RMTI earnings summariesRMTI Stock 12 Month Forecast
Average Price Target
$3.75
▲(290.63% Upside)
Technical Analysis
Ownership Overview
15.33% Insiders
4.35% Mutual Funds
0.93% Other Institutional Investors
75.81% Public Companies and Individual Investors